Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVietnam Enterprise Investments Regulatory News (VEIL)

Share Price Information for Vietnam Enterprise Investments (VEIL)

Share Price is delayed by 15 minutes
Get Live Data
767.00    1.00 (0.13%)
Bid:
767.00
Ask:
774.00
Spread: 7.00 (0.913%)
Market Cap: £1.05b
VEIL Live PriceLast checked at - London Stock Exchange

Intraday Vietnam Enterprise Investments Share Chart

Half-year Report

22 Sep 2025 07:00

RNS Number : 2190A
Vietnam Enterprise Investments Ltd
22 September 2025
 

COMPANY ANNOUNCEMENT

 

For Immediate Release

 

22 September 2025

 

Vietnam Enterprise Investments Limited

("VEIL" or the "Company")

 

INTERIM RESULTS FOR THE SIX-MONTH PERIOD ENDED 30 JUNE 2025

 

The Company today announces its interim results for the six-month period ended 30 June 2025 (the "Interim Report 2025").

 

The Interim Report 2025 has been filed with the FCA by uploading it to the National Storage Mechanism ("NSM") in accordance with UK Listing Rule 6.4.1 and will shortly be available for inspection at:

 

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

The Interim Report 2025 may also be accessed via the Company's website:

 

https://www.veil-dragoncapital.com/investors/financial-statements/

 

In accordance with DTR 6.3.5(1A), the regulated information referred to in DTR 6.3.5 is available in unedited full text within the Interim Report 2025 as uploaded to the NSM and on the Company's website as noted above.

 

Performance highlights:

 

· Post-reporting period outperformance:

Since the period end to 31 August, VEIL has outperformed the VNI by around 4%, rising 25.5% in USD terms and 27.2% in GBP terms. This post-period performance highlights the resilience of VEIL's positioning in sectors most closely tied to domestic demand and underscores the strength of the long-term investment case.

· Over the reporting period:

NAV per ordinary share rose by 0.9% in US$ terms

Increase in share price of 9.0% in US$ terms

Discount narrowed to 14.9% (from 21.2% as at 31/12/24)

Total net assets USD1.7bln (31/12/24: USD1.8bln)

NAV per share USD9.8

The Company bought back 9.27 million shares, representing 5.0% of the issued share capital, at an average discount of 20.6%

The VNI gained 6.9% in total return US$ terms

At the AGM in June, shareholders voted in favour of continuation for a further five years

 

Sarah Arkle, Chair of the Board, VEIL, commented:

 

"The first six months of 2025 combined strong domestic momentum in Vietnam with periods of volatility triggered by external events such as tariff disputes and wider geopolitical uncertainty. Against this backdrop, VEIL maintained its focus on long term capital growth through its exposure to Vietnam's internal growth drivers. As clarity on trade tariffs improved, sentiment stabilised and the equity market saw a sharp recovery.

 

"With Vietnam's government reform momentum intact, a strong economy, and rising savings, Vietnam continues to offer one of the most compelling growth stories in emerging markets. The potential upgrade to FTSE Emerging Market status would represent an important milestone, and would broaden Vietnam's investor base."

 

Tuan Le Anh, Lead Portfolio Manager, VEIL, commented:

 

"Vietnam's GDP grew 7.5% in 1H25, a near twenty-year high. This growth feels more durable; it remains domestically driven, aligned with our core exposures in banks, real estate and consumption. Reforms continued to reshape the policy landscape. They are unprecedented and creating a clearer runway for the private sector, the part of the economy where VEIL is most invested.

 

"Trade tensions eased; we believe the direct effect on listed equities is limited. Despite volatility, the VNI gained 6.9% in 1H25 in total return US$ terms, reaching its highest level since 2021. Looking ahead, the prospect of a FTSE Emerging Market upgrade remains a structural catalyst. We remained focused on the domestic growth drivers, consumption, banking, infrastructure, while actively managing tariff-driven volatility, with very little direct exposure to US-focused export revenues.

 

"As we enter the second half of 2025, our conviction in Vietnam's trajectory remains strong. Attractive valuations relative to peers, combined with strong earnings growth, provide a solid foundation for returns. Looking further ahead into 2026, our priority is to keep VEIL overweight in Vietnam's domestic leaders in banks, real estate and consumption, while selectively building positions in infrastructure and industrials that will benefit most from reform and inbound capital."

 

 

Enquiries:

 

Vietnam Enterprise Investments Limited

Steven Mantle

+44 (0) 755 370 1237

stevenmantle@dragoncapital.com

Jefferies International Limited

Stuart Klein

+44 (0) 20 7029 8703

stuart.klein@jefferies.com

 

h2Radnor

Iain Daly

+44 (0) 20 3897 1830

idaly@h2radnor.com

 

Montfort Communications

Gay Collins, Alex Everett

+44 (0) 7798 626282

veil@montfort.london

 

LEI: 213800SYT3T4AGEVW864

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FIFISAEIFFIE
Date   Source Headline
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSNet Asset Value(s)
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:48 amRNSNet Asset Value(s)
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSNet Asset Value(s)
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSNet Asset Value(s)
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSNet Asset Value(s)
28th Jan 20267:00 amRNSNet Asset Value(s)
27th Jan 20267:00 amRNSNet Asset Value(s)
26th Jan 20267:00 amRNSNet Asset Value(s)
23rd Jan 20267:00 amRNSNet Asset Value(s)
22nd Jan 202610:58 amRNSTotal Voting Rights (Replacement)
22nd Jan 20267:00 amRNSNet Asset Value(s)
21st Jan 20261:46 pmRNSRepurchase of Exit Shares - Total Voting Rights
21st Jan 20267:00 amRNSNet Asset Value(s)
21st Jan 20267:00 amRNSDirectorate change
20th Jan 20268:27 amRNSNet Asset Value(s)
19th Jan 20267:00 amRNSTender Pool Allocation and Tender Price
19th Jan 20267:00 amRNSNet Asset Value(s)
16th Jan 20263:26 pmRNSResult of Tender Offer
16th Jan 20267:00 amRNSNet Asset Value(s)
15th Jan 20267:00 amRNSNet Asset Value(s)
14th Jan 20267:00 amRNSNet Asset Value(s)
13th Jan 20267:00 amRNSNet Asset Value(s)
12th Jan 20267:00 amRNSNet Asset Value(s)
9th Jan 20267:00 amRNSNet Asset Value(s)
8th Jan 202611:47 amRNSResult of General Meeting
8th Jan 20267:00 amRNSNet Asset Value(s)
7th Jan 20267:00 amRNSNet Asset Value(s)
7th Jan 20267:00 amRNSDiscount Management Update
6th Jan 20267:00 amRNSNet Asset Value(s)
5th Jan 20267:00 amRNSNet Asset Value(s)
31st Dec 20257:00 amRNSNet Asset Value(s)
30th Dec 20257:00 amRNSNet Asset Value(s)
29th Dec 20257:00 amRNSNet Asset Value(s)
29th Dec 20257:00 amRNSNet Asset Value(s)
24th Dec 20257:00 amRNSNet Asset Value(s)
23rd Dec 20257:00 amRNSNet Asset Value(s)
22nd Dec 20259:20 amRNSDirectorate change
22nd Dec 20259:20 amRNSDirectorate change
22nd Dec 20257:00 amRNSNet Asset Value(s)
19th Dec 20257:00 amRNSNet Asset Value(s)
18th Dec 20257:00 amRNSNet Asset Value(s)
17th Dec 20257:00 amRNSNet Asset Value(s)
16th Dec 20257:00 amRNSNet Asset Value(s)
15th Dec 20257:00 amRNSNet Asset Value(s)
15th Dec 20257:00 amRNSTender Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.